BioPharm Asia, Inc. Introduces Beijing Zhihe Ruikang Hospital Management Ltd.

NEW YORK & TONGHUA, China--(BUSINESS WIRE)--BioPharm Asia, Inc. (OTCBB: BFAR; “BFAR” or the “Company”), a producer, distributor and retailer of medical products in China, announced last Friday that its wholly-owned subsidiary, China Northern Pharmacy Holding Group Limited, had entered into an agreement to acquire all of the outstanding shares of Beijing Zhihe Ruikang Hospital Management Ltd. (“ZHRK”), a professional Chinese hospital management consulting group, for a consideration of RMB2,400,000 (approximately $350,000). This transaction is expected to close in early July.

Back to news